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ABSTRACT 
Human endogenous retroviruses (HERV) comprise 8% of the human genome and can be 
classified into at least 31 families. A typical HERV provirus consists of internal gag, pol and 
env genes, flanked by two long terminal repeats (LTRs). HERV are by nature repetitive and 
have with few notable exceptions lost their protein-coding capacity. Therefore, HERV are 
consistently not included in large scale expression studies and hence little is known of their 
expression, regulation and potential functional significance. Aberrant expression of HERV-W 
has been associated with human diseases, such as multiple sclerosis and schizophrenia. It has 
been reported that HERV-W elements, including ERVWE1 (the so far only known HERV-W 
gene functionally adopted by the human host), can be transactivated in a range of human non-
placental cell-lines during influenza virus infections.  
        Applying a recently developed technique for obtaining high resolution melting temperature 
analyses, transcripts containing HERV-W gag sequences were found to be expressed in non-
random patterns with extensive variations in the expression between tissues, brain regions and 
individuals. Furthermore, the patterns of such transcripts varied more between individuals in 
brain regions than other tissues (I). To determine the effect of genomic context, viral structure 
and orientation on the transcription of HERV-W, PCR directed at specific HERV-W loci were 
employed on panel of normal human tissues. HERV-W elements in intronic regions were found 
to be expressed at higher levels than elements in intergenic regions. With regard to intronic 
elements, proviruses were expressed at higher levels than pseudoelements or solo LTRs. 
Relative to their corresponding genes, intronic elements integrated on the sense strand appeared 
to be transcribed at higher levels than those integrated on the anti-sense strand. Furthermore, the 
expression of transcripts containing intronic proviral elements appeared to be independent from 
that of their corresponding genes (II). When addressing mechanisms underlying transactivation 
of HERV-W following virus infection we detected up-regulation of spliced ERVWE1 
transcripts and those encoding the transcription factor glial cells missing 1 (GCM1) which acts 
as an enhancer element upstream of ERVWE1. Knock-down of GCM1 by siRNA, followed by 
infection suppressed the transactivation of ERVWE1. In addition, ChIP assays detected 
decreased H3K9 trimethylation and histone methytransferase SETDB1 levels along with 
influenza viral proteins associated with ERVWE1 and other HERV-W loci in infected CCF-
STTG1 cells (III). Finally, by analyzing publicly available RNA sequencing datasets generated 
from three different regions of human brains of multiple individuals, a consistent expression 
(0.1-0.2% of mappable reads) of HERV families was observed across three regions of brains. 
Spearman correlations between tissues revealed highly correlated expression levels across 475 
consensus sequences. By mapping sequences aligned to the consensus sequences of HERV-W 
and HERV-H families to individual loci on chromosome 7, more than 60 loci from each family 
were identified, some of which are being transcribed. Elevated expressions of overall HERV, as 
well as of HERV-W family were observed in samples from both schizophrenia and bipolar 
disorder patients (IV).  
        
In conclusion, our studies show that 1) HERV-W gag transcripts appear to exhibit a highly 
diversified expression pattern across both tissues and individuals; 2) Both LTR directed and 
leaky transcription of HERV-W elements contribute to their tissue-specific expression pattern; 
3) Chromatin modifications potentially mediate the effect of influenza A virus infection on 
HERV-W expression; 4) An independent method of RNA sequencing verifies expression of 
HERV in human brain regions.  
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1 INTRODUCTION 
1.1 HUMAN ENDOGENOUS RETROVIRUSES 
The human genome has a total of over 3 billion DNA base-pairs. Whereas only 2% of 
the genome is composed of protein-coding regions, approximately 45% of our DNA is 
recognized as containing transposable elements which have by and large been 
considered as “junk” (Lander et al., 2001; Venter et al., 2001). These elements consist 
of four types, i.e. long interspersed elements (LINE), short interspersed elements 
(SINE), DNA transposons and long terminal repeat (LTR) retrotransposons including 
human endogenous retroviruses (HERV). By using whole transcriptome sequencing, 
around 8% of mappable reads has been reported to originate from these repeat 
sequences in human cortex (Tyekucheva et al., 2011).  
 
There are seven genera in the retroviridae family; alpharetroviruses, betaretroviruses, 
gammaretroviruses, deltaretroviruses, epsilonretrovirus, lentivirus and spumavirus, see 
chapter 57 in the text book (Knipe et al., 2001). HERVs constitute 8% of the human 
genome and have been broadly grouped into three classes based on sequence 
similarities. Class I contains HERVs related to gammaretroviruses (e.g. murine 
leukemia virus, MLV), including HERV-W and HERV-H; class II HERVs are related 
to betaretrovituses (e.g. mouse mammary tumor virus) and include several subgroups of 
HERV-K; while class III HERVs are related to spumaviruses (e.g. chimpanzee foamy 
virus), including HERV-L and HERV-S (Tristem, 2000), reviewed in (Bannert and 
Kurth, 2004; Griffiths, 2001). HERV sequences exist in multiple copies across different 
chromosomes and therefore are by nature repetitive. With a few notable exceptions, 
HERVs have lost their protein-coding capacity. For these reasons, HERV are 
consistently ignored in large scale expression studies and thus tremendous is not well 
understood regarding their expression, regulation and potential functional significance. 
 
1.1.1 Evolution 
ERVs are exogenous retroviruses that are believed to have integrated into the germ-line 
of the host, see chapter 9 in the text book (Boeke and Stoye, 1997). These sequences 
are widespread in many animal species such as mice; ERVs account for about 10% the 
mouse genome. The inserted ERVs, for instance, can detrimentally cause mutations in 
the host gene (e.g. supply alternative splicing or termination signals), leading to the loss 
of host from the population. On the other hand, a few selective advantages can be 
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provided by ERV insertions. For example, through evolution a positive pressure results 
in the functional preservation of ERVWE1 locus of HERV-W family, which is critically 
involved in the morphogenesis of human placenta (Mallet et al., 2004), see section 1.4 
below. Most of inserted ERV sequences are neutral and have persisted in the host 
genome. 
  
HERV (coined “fossil viruses”) are the ancient remnants of retroviral infections that 
integrated in the germ-line of human ancestors, reviewed in (Jern and Coffin, 2008; 
Kurth and Bannert, 2010; Mayer and Meese, 2005; Stoye, 2001). At least 31 HERV 
families have been identified, each derived from a single horizontal transmission event 
by an exogenous virus infection, followed by germ-line integration, inherited in a 
Mendelian fashion and have become fixed into the population during the evolution of 
the human lineage (Katzourakis and Tristem, 2005). In addition to reinfection, the 
mechanism of intracellular retrotransposition has been used by HERVs to expand their 
copy numbers within the genome (Belshaw et al., 2005). Intracellular retrotransposition 
is mediated by reverse transcriptase (RT) machinery, which takes place in a 
cytoplasmic virus-like particle primed by a cellular transfer RNA (tRNA). The 
nomenclature of HERV is primarily based on the tRNA specificity of the primer 
binding site (PBS), reviewed in, (Griffiths, 2001). For instance, the W family of HERV 
implies that it uses a tryptophan tRNA, which one letter code is W, for priming of 
reverse transcription. However, the great majority of HERV identified to date are 
defective and have lost the capacity for horizontal transmission. No single HERV 
element has been found to generate infectious particles, while reconstruction of 
infectious version of extinct HERV-K elements was reported from two independent 
groups (Dewannieux et al., 2006; Lee and Bieniasz, 2007).  
 
HERV are detectable in the genomes of all Catarrhini, including humans, 
chimpanzees, gorillas, orangutans, gibbons and Old World monkeys (e.g. rhesus 
monkeys and baboons). The groups of class I and III HERVs are relatively old; HERV-
H (class I) family, for example, is most abundant and inserted in genome prior to the 
divergence between Old and New World monkeys (e.g. squirrel monkeys and 
marmosets) over 40 million years ago (Mager and Freeman, 1995), while the W family 
of HERV has been considered to enter the human genome after the divergence of Old/ 
New World monkeys over 30 million years ago (Kim et al., 1999; Voisset et al., 1999). 
The youngest class II HERVs have been active (retain horizontal transmission) through 
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the last 5~25 million years, although several HERV-K (HML-5) elements are detected 
in New World monkeys, which integrated in the genome already 55 million years ago 
(Lavie et al., 2004). 
 
1.1.2 Structure 
HERVs are readily recognized in terms of their retroviral gene structure. According to 
the text book (Coffin et al., 1997), “a HERV provirus consists of internal group-specific 
antigen (gag), polymerase (pol) and envelope (env) genes flanked by more or less 
identical LTRs. These three genes: gag encodes important proteins to form structure of 
viral core, including capsid, matrix and nucleocapsid; pol encodes the viral enzymes, 
including protease (PR), reverse transcriptase (RT), RNAse H and integrase (IN); and 
env encodes the viral envelope glycoproteins. LTRs contain a range of regulatory 
sequences such as effective promoters, enhancers and transcription factor binding sites. 
The LTR is composed of U3, R and U5 regions. The U3 region of 5’LTR acts as 
proviral promoter, while the R region located in the 3’LTR serves as a polyadenylation 
signal. There are several regulatory elements located in the internal viral genome, 
including splice donor (SD) and acceptor (SA) sites which are involved in env 
expression (see section splicing of ERVWE1 transcripts below) and PBS for tRNA 
specific binding to initiate reverse transcription. Typical inactivating mutations 
originated from point mutations, deletions and frameshift retained in the three genes 
during the evolution. In addition, solitary LTRs, created by homologous recombination 
between the two LTRs generating to loss of the entire internal sequence, are frequently 
present in the human genome”. 
 
1.1.3 Distribution and expression 
HERV elements are widely distributed in the human genome. Except for chromosomes 
8, 13, 21 and 22, Yi and coworkers identified 70 env fragments of HERV-H across the 
other 20 chromosomes (Yi and Kim, 2004). A comprehensive analysis of HML-2 
elements (HERV-K family), including 91 proviruses and 944 solo LTRs, has been 
reported recently (Subramanian et al., 2011). HERV insert in both genic and intergenic 
regions of the genome, but the majority of HERV families are more likely located in 
intergenic regions. From another aspect, HERV can be located in sense or antisense 
orientations of either introns or adjacent regions of annotated genes. Intronic HERV 
exhibit a significant antisense bias (van de Lagemaat et al., 2006).  
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Although all HERV elements are considered non-infectious and the vast majority is 
probably non-functional, there are a considerable number of studies that investigate 
their expression. In these studies, methods like microarray and quantitative polymerase 
chain reaction (qPCR) have most frequently been employed. HERV have been reported 
to be differentially expressed across human tissues and cell-types, with considerable 
expression in placenta but less expression in other tissues (Forsman et al., 2005; Pichon 
et al., 2006; Schon et al., 2001; Seifarth et al., 2005; Stauffer et al., 2004; Yi et al., 
2004). Moreover, aberrant expression of HERV have been associated to human 
diseases (Frank et al., 2005; Frank et al., 2008; Hu et al., 2006; Johnston et al., 2001; 
Lower et al., 1993; Sekigawa et al., 2003). For example, HERV-K transcripts and 
proteins are expressed at higher levels in a series of cancers and autoimmune diseases. 
Increased expression of HERV pol RNA and proteins, most likely originating from 
ERV9 family, have been detected in blood samples from schizophrenia patients (Huang 
et al., 2006). HERV-H has been reported to be up-regulated in tissues from patients 
with multiple sclerosis (MS), reviewed in (Christensen, 2010).  
 
1.2 HERV-W EXPRESSION 
Following its integration into the human germ-line 30 million years ago, HERV-W is 
today found in many copies scattered throughout the human genome. Like other HERV 
elements, HERV-W is preferentially expressed in normal human placenta (Blond et al., 
1999; Forsman et al., 2005; Stauffer et al., 2004). Differential expression of HERV-W 
has also been observed in various human tissues and cells. Hybridization-based studies 
detected HERV-W transcripts in a variety of human normal tissues, in particular, in 
placental and testis tissues (Seifarth et al., 2005). From results obtained by using a pol-
probe, Schon and coworkers reported HERV-W transcripts in kidney and liver cells 
(Schon et al., 2001). Applying RT-PCR, the structural genes (gag, pol and env) of 
HERV-W were also found to be highly expressed in normal human placenta and testis 
out of 12 human normal tissues and 18 human cancer cells investigated. In addition, the 
gag gene was specifically transcribed in normal brain and spleen tissues but in none of 
the cancer cells. With the exception of normal heart and uterus tissues and three cell-
lines, pol transcripts were widely observed in normal tissues and cancer cells. In 
contrast, env transcripts were expressed in all the tissues and cells tested (Yi et al., 
2004). Expression of the HERV-W family has been reported in association with human 
diseases, such as cancer, MS and schizophrenia (see section 1.6 below).  
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Despite the differential detection of HERV-W in normal or pathological tissues, the 
repetitive nature of these sequences makes it difficult to identify expression of single 
elements for methodological reasons. Previous studies from our laboratory indicated a 
cell-specific transcription of a range of HERV-W elements in cell-lines of human 
origin. Such expression patterns of HERV-W gag and env genes were observed by 
using an analysis of amplicon melting temperatures (Tm). Since the unspecific 
designed primers were used to target toward HERV-W gag or env sequence, the 
different analyzed amplicons were grouped into 3~4 categories according to the 
discrete Tm ranges (Nellaker et al., 2006). This previously applied approach with low 
resolution limits the determination of sequence differences between amplified products. 
Furthermore, the extent of transcription of individual members of HERV-W across 
tissues and individuals has not been investigated.  
 
1.3 HERV-W STRUCTURE  
As for other HERVs, HERV-W in the human genome contains a number of elements 
with prototypical structure (denoted proviral elements, i.e. internal gag, pol and env 
genes flanked by two intact LTRs) but also elements bearing the hallmarks of 
processed pseudogenes (denoted pseudoelements) and elements that cannot be 
classified into either of these categories due to extensive deletions/truncations (denoted 
truncated elements), Figure 1.  
  
 
Figure 1 Schematic illustration of the 
structures of provirus, pseudoelement, 
truncated element and solo LTR. (Figure 
modified from “Li F, Nellåker C,Yolken RH 
and Karlsson H. A systematic evaluation of 
expression of HERV-W elements; influence 
of genomic context, viral structure and 
orientation. BMC Genomics. 2011”) 
 
The pseudoelements in common lack the U3 region of 5’LTR and the U5 region of 
3’LTR, while truncated elements only displaying partial internal sequences. The U3 
region of the LTR contains the regulatory motifs necessary for expression, therefore 
pseudoelements and truncated elements are presumably transcriptional silent (Costas, 
2002). The HERV-W pseudoelements are typically characterized by their colinear 
structure with retroviral mRNA followed by poly(A) tails. Moreover, the majority of 
pseudoelements are flanked by direct repeats (i.e. a sequence is repeated with the same 
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pattern downstream) that are longer than those flanking proviruses (normally flanked 
by direct repeats of 4 bp) and displays a preference for TT|AAAA insertion motif 
similar to processed pseudogenes. These pseudoelements thus have been suggested to 
be generated by RT actively provided by LINE acting on the proviral transcripts. In 
contrast to very few detected pseudoelements in other HERV families (for instance less 
than 1% of HERV-H are pseudoelements), numerous pseudoelements (one fourth) have 
been observed in HERV-W which distinguishes it from other HERV families. In 
addition, the HERV-W family also contains a large number of solitary LTRs which 
account for at least half of the all elements in this family (Belshaw et al., 2005; Costas, 
2002; Pavlicek et al., 2002). 
 
As mentioned above, we previously observed transcription of HERV-W gag and env 
sequences in various cell-types. Surprisingly, cloning and sequencing data indicated 
that these detected transcripts could be mapped to three categories of HERV-W 
elements, including both proviral elements and elements lacking regulatory LTRs. In 
addition, mapped elements were located in both intronic and intergenic regions 
throughout the human genome (Nellaker et al., 2006; Yao et al., 2007). Whether 
transcription of HERV-W is initiated from the U3 region of the LTR or from promoters 
in flanking regions is therefore not clear.  
 
1.4 SYNCYTIN-1 EXPRESSION 
1.4.1 Biological role of syncytin-1  
A group of studies have identified several env, with full-length open reading frames 
(ORF) able to produce potentially functional proteins, from different HERV families 
(de Parseval et al., 2003; Dewannieux et al., 2005; Villesen et al., 2004). ERVWE1, 
located on chromosome 7q21.2, is so far the only verified HERV-W proviral locus that 
has retained coding capacity. The product of the env glycoprotein gene, is termed 
syncytin-1 and appears to be exclusively expressed in the syncytiotrophoblast layer of 
the placenta. This gene, thus, appears to have been functionally adopted by the human 
host (Mallet et al., 2004; Mi et al., 2000; Voisset et al., 2000).  
 
The syncytin-1 protein contains 538 amino-acids (AA), which structurally consists of a 
surface subunit (SU, AA1-317) and a transmembrane subunit (TM, AA318-538). SU is 
involved in receptor recognition and binding (Cheynet et al., 2006), while TM contains 
several fusion core peptides (Gong et al., 2005) and a putative immunosuppressive 
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domain (IM, AA377-396). In the placenta, syncytin-1 mediates trophoblast cell-cell 
fusion upon interaction with the D type mammalian retrovirus receptor (RDR, also 
known as neutral amino acid transporters, ASCT1 and ASCT2) (Blond et al., 2000; 
Lavillette et al., 2002). Other biological functions of syncytin-1 remain uncertain. A 
recent study reported that syncytin-1 serves the potential function of promoting 
trophoblast cell proliferation (Huang et al., 2013). Studies of The immune modulatory 
effect of syncytin-1 have provided different results. The tumor-rejection assay in mice 
model revealed that syncytin-1 is not immunosuppressive (Mangeney et al., 2007). 
However, syncytin-1 has recently been suggested to exert immunosuppressive function 
in lipopolysaccharide or phytohaemagglutinin stimulated human blood culture immune 
systems, which may play a role in maternal immune tolerance (Tolosa et al., 2012).  
 
1.4.2 Regulation and expression of syncytin-1  
ERVWE1 is composed of inactivated gag and pol genes and intact preserved env ORF 
(containing a specific 12 bp deletion which is located in the intracytoplasmic tail, 
AA471-538, and is pivotal for the constitutive fusogenic activity of syncytin-1), 
flanked by two intact LTRs. A 247 bp LTR retroviral promoter (U3 region of 5’LTR) 
cooperates with a 436 bp upstream regulatory element (URE) region, to regulate 
ERVWE1 expression in the placenta. Whereas the U3 region from position +1 to +125 
represents a basal placental promoter activity, remaining region of U3 in concert with 
part of R region (63 bp) suggests a cyclic adenosine monophosphate (cAMP)-
responsive core promoter activity in all cell-types. Activation of cAMP/Protein Kinase 
A (PKA) pathway increase expression of ERVWE1 and can induce syncytia formation 
in human trophoblast cells. The URE consist of a 208 bp non-retroviral sequence and a 
228 bp mammalian apparent LTR-retrotransposon (MaLR) (Smit, 1993) LTR 
containing a 33 base-pair long trophoblast specific enhancer (TSE) region (-67~-35), in 
which a series of putative transcription binding sites are included, conferring a high and 
specific expression in the placenta (Bonnaud et al., 2005; Cheng et al., 2004; Mi et al., 
2000; Prudhomme et al., 2004), see Figure 2.  
 
Transcription factors 
Several transcription factor binding sites, including Sp-1, GATA, Oct-1 and GCM1, 
have been identified in the TSE and promoter region (Figure 2).  Transcription factor 
Sp-1, encoded by the SP1 gene, can bind to GC-rich motifs of many promoters. It acts 
as an activator or repressor by post-translational modification such as phosphorylation 
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or acetylation, playing a critical role in regulating gene expression. GATA transcription 
factors represent a family of six closely related and evolutionarily conserved sequence-
specific DNA-binding proteins, GATA1 to 6, contributing to gene regulation. Oct-1 
belongs to the family of octamer transcription factors, which are characterized by their 
ability to bind to the “ATTTGCAT” sequence, which is important in the modulation of 
gene expression. These transcription factors have been shown to be involved in the 
ERVWE1 promoter placental regulation (Cheng and Handwerger, 2005; Cheng et al., 
2004), reviewed in (Loregger et al., 2003). 
 
      
Figure 2 Schematic representation of the ERVWE1 transcriptional regulatory elements. An 
upstream regulatory element (URE) and LTR retroviral promoter synergistically regulate ERVWE1 
transcription. The start and end bases of each constituent element are indicated at the bottom. 
Transcription starts at the U3/R boundary (arrow). CAAT and TATA boxes as well as effective transcription 
factors binding sites along the MaLR[LTR] and ERVWE1[5'LTR] are indicated. The GCM1 binding site is 
underlined. The top relative positions of the CpG sites located two LTR regions are illustrated by circles on 
vertical bars. (Figure modified from “Prudhomme S, Oriol G and Mallet F. A retroviral promoter and a 
cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol, 
2004”) 
 
GCM1, a highly conserved DNA-binding protein with a glial cells missing (gcm) 
motif, is a member of the Gcm protein family. The gcm gene was first identified in 
Drosophila as being involved in the glial cell fate specification by mediating neural 
stem cell (NSC) differentiation and promoting glial cell proliferation. In contrast, 
mammalian Gcm proteins are highly expressed in the placenta but expressed at low 
levels in the mature central nervous system (CNS), reviewed in (Mao et al., 2012). 
However, Iwasaki and coworkers has previously reported that mouse Gcm1 expression 
induce gliogenesis both in vitro and in vivo (Iwasaki et al., 2003). A previous study 
from our group reported that the levels of transcripts encoding Gcm1 are expressed 
highest at embryonal day 17 to postnatal day 7 and substantially decline at later time-
points in mouse brain tissue (Asp et al., 2007). These findings suggest that Gcm1 also 
plays a role in mammalian CNS development. Otherwise, GCM1, is considered a 
   9 
trophoblast-specific transcription factor and binds to the GCM1 binding site (GCM 
motif (A/G)CCCGCAT) located in the TSE region of ERVWE1, which greatly enhance 
promoter activity particularly in human placental cells (Nait-Oumesmar et al., 2000; Yu 
et al., 2002). Decreased transcription of ERVWE1 has been observed under conditions 
of low oxygen in choriocarcinoma BeWo cells (Knerr et al., 2003). Induction of 
cAMP/PKA pathway compensates reduced ERVWE1 expression by hypoxia since this 
pathway activation increases expression of GCM1 and subsequently stimulates 
ERVWE1 transcription in trophoblast cells (Chang et al., 2005).  
 
In addition, an oestrogen receptor (ER) binding site (i.e. oestrogen response element, 
ERE) and conventional CAAT and TATA boxes (overlapping with cAMP response 
element, CRE) located in the basal and core promoter respectively, which are essential 
to the promoter activation. The latter can be induced by the cAMP/PKA pathway, while 
ER bind specifically to the ERE to regulate ERVWE1 transcription. 
 
     
Figure 3 Schematic illustration of the ERVWE1 splicing strategy. The transcription initiation site and 
the polyadenylation signal are indicated as thin right and left arrows, respectively. Splice donor (SD) and 
acceptor (SA) sites are indicated by thick right and left arrow heads, respectively. Non-spliced and spliced 
transcripts of ERVWE1 can be detected by using the paired-assays which are indicated by thick right and 
left arrows. Only the 2.8-kb variant is responsible for syncytin-1 translation. (Figure modified from 
“Trejbalová K, Blazková J, Matousková M, Kucerová D, Pecnová L, Vernerová Z, Herácek J, Hirsch I, and 
Hejnar J. Epigenetic regulation of transcription and splicing of syncytins, fusogenic glycoproteins of 
retroviral origin. Nucleic Acids Res, 2011”) 
 
Splicing of ERVWE1 transcripts 
According to Trejbalova et al (Trejbalova et al., 2011), the ERVWE1 full-length pre-
mRNA includes a 2.1 kb intron, which can be detected in BeWo cells. Two mRNA 
transcripts are mainly generated after the splicing process; a 7.5 kb spliced transcript 
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which contains the gag, pol and env frames and a 2.8 kb subgenomic-spliced env 
transcript which is responsible for syncytin-1 translation, Figure 3. The two spliced 
ERVWE1 transcripts are rarely expressed in non-placental cells in contrast to their high 
expression levels in trophoblastic cells. Northern blot previously detected two spliced 
transcripts in human placenta but with low levels in other tissues (Mi et al., 2000). In 
addition, ERVWE1 produces a small 1.3 kb spliced transcript. The 5’splice signal 
located at the end of U5 region produce these three major single-spliced transcripts, in 
combination with three different SA sites. Another SD site located at the 5'UTR of env 
ORF may give rise to presence of other splice variants (Blond et al., 1999). The 
splicing strategy of ERVWE1 has been conserved among apes (Mallet et al., 2004). 
 
Epigenetic and chromatin modification 
DNA methylation is a biochemical process, implicated in the control of genomic 
imprinting, X chromosome inactivation, expression of endogenous retroviral sequences 
and tumorigenesis. The enzymes, DNA methyltransferases (Dnmts), catalyze the 
transfer of a methyl group to DNA during this process, leading to a general gene 
silencing. Three active Dnmts (Dnmt1, Dnmt3a, and Dnmt3b) that appear to establish 
and maintain DNA methylation patterns have been identified in the embryonic and 
neural development in mouse and human (Feng et al., 2010; Vassena et al., 2005), 
reviewed in (Kim et al., 2009). Gimenez and co-workers observed a hypomethylation 
of the ERVWE1 promoter and TSE, along with high levels of mRNA encoding 
syncytin-1 in the placenta and BeWo cells (Gimenez et al., 2009). Methylation profiles 
from placentas of twins also indicated an inverse correlation between methylation 
levels of the ERVWE1 promoter and its mRNA and protein levels (Gao et al., 2012). In 
contrast, suppression of expression of syncytin-1 stems from extensive 5’ LTR 
methylation has been detected in non-placental cells such as peripheral blood 
mononuclear cells (PBMC), skin fibroblast and Hela cells (Matouskova et al., 2006).  
 
In addition to DNA methylation, chromatin modification is another mechanism for 
gene regulation. The chromatin subunit, denoted as nucleosome, consists of 147 bp of 
DNA wrapped around eight histone protein cores (two copies of each of four core 
histones H2A, H2B, H3 and H4). Each core histone has a C-terminal histone-fold 
domain and a positively charged N-terminal, containing many lysine and arginine 
residues. Most post-translational covalent modifications occur within the N-terminal, 
which appears as an extensive tail protruding from the nucleosome. Histone 
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modifications such as acetylation and methylation are involved in the control of 
transcription. Whereas acetylation of histone H3 lysine 9 (H3K9Ac) is well-known to 
correlate with active transcription, tri-methylation of H3K9 (H3K9Me3) has been 
linked with transcriptional repression (Barski et al., 2007; Rosenfeld et al., 2009). 
Immunoprecipitation of ERVWE1 promoter associated chromatin indicated high 
H3K9Ac but low H3K9me3 levels in BeWo cells, which corresponds to the active 
transcription of this locus. In contrary, transcriptional suppression of ERVWE1 was 
detected in Hela cells, accompanied with high enrichment of H3K9me3 but low 
H3K9Ac at its 5’LTR region (Trejbalova et al., 2011). Hypermethylation of ERVWE1 
observed in non-placental cells (described above) is accompanied by H3K9 
deacetylation, as well as H3K9me3 (Matouskova et al., 2006).  
 
In contrast to genic promoter regions, class I and II ERVs are both highly DNA 
methylated and marked by H3K9me2 and H3k9me3 in mouse embryonic stem cells 
(mESCs) (Dong et al., 2008). A DNA methylation-independent pathway has been 
shown to be involved in the proviral silencing of ERVs in mESCs through H3K9me3 
(Matsui et al., 2010). H3K9-specific lysine methyltransferases (KMTase) G9a and 
SETDB1, which are required for H3K9me2 and H3K9me3, respectively, are 
demonstrated to play crucial roles in the silencing of proviruses in mESCs (Leung et 
al., 2011; Matsui et al., 2010). Comparison of Dnmts- and SETDB1-mediated pathways 
in suppressing genes and retroelements in mESCs has been well characterized recently. 
Genome-wide profiling revealed that de-repression of class I and II ERVs with 
concomitant H3K9me3 loss is due to the depletion of SETDB1 rather than Dnmts 
(Karimi et al., 2011). These findings suggest that suppression of ERVWE1 in non-
placental cells is under the control of KMTases-mediated H3K9me2/3 independent of 
the methylation status of its promoter.  
 
1.5 RELATIONSHIP BETWEEN HERV-W AND VIRUS 
1.5.1 Transcription activation of HERV-W 
In previous studies, dysregulation of ERVWE1 has been shown to be associated with 
various exogenous stimuli. As mentioned above, oxygen deficiency gives rise to 
decreased expression levels of syncytin-1 (Knerr et al., 2003). Serum deprivation 
increase transcription of HERV-W elements in vitro (Nellaker et al., 2006). Viral 
infection can trigger transactivation of HERV-W. Induction of HERV-W by herpes 
virus simplex type I (HSV-1) infection has been observed in neuronal and brain 
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endothelial cells (Nellaker et al., 2006; Ruprecht et al., 2006). In addition, activation of 
HERV-W by Epstein-Barr virus (EBV) was recently observed in blood cells and 
astrocytes (Mameli et al., 2012).  
 
1.5.2 Influenza A/WSN/33 virus infection 
Influenza A viruses are negative-sense, single-stranded viruses with 8 RNA segments 
that encode 11 proteins, see Table 1 (chapter 46 in the text book (Knipe et al., 2001)). 
Based on the type of two proteins on the surface of the viral envelope, hemagglutinin 
(HA) and neuraminidase (NA), 18 subtypes of HA and 11 subtypes of NA have been 
found so far. Influenza A/WSN/33 virus, of the H1N1 subtype, is a neurotropic mouse 
adapted strain which can be easily grown on Madin-Darby canine kidney (MDCK) 
cells.  
 
Table 1 The segments of influenza A virus and their encoded proteins 
Segment Encoding protein (s) Function 
1 PB2 (RNA polymerase) 
2 PB1 (RNA polymerase) 
& PB1-F2 & N40 
3 PA (RNA polymerase) 
i) PB2 recognize mRNA cap, PB1 mediate RNA 
elongation, PB1-F2 mediate pro-apoptosis, PA cleaves 
the cap from the host’s RNA 
ii)  ssRNA is associated with PA&PB1&PB2 and coated 
with NPs to form ribonucleoprotein complex (vRNPs) 
4 HA (hemagglutinin) Mediates binding of virions to the target cells and entry 
of the viral genome into the target cell 
5 NP (nucleoprotein) Bind to viral ssRNA; regulate nuclear import  
6 NA (neuraminidase) Mediates release of progeny virions from infected cells 
7 M1(matrix proteins) 
&M2  
Mediates attachment of vRNPs to lipid bilayer 
membrane through ion channel 
8 NS1& NS2(NEP)  
(non-structure proteins) 
Binds to host cell pre-mRNA transcripts to regulate host 
gene expression; regulate RNA export 
 
An influenza A/WSN/33 virus infection induced transactivation of HERV-W elements, 
including ERVWE1 locus, has been observed in a range of human cell-lines of non-
placental origin (Nellaker et al., 2006). The mechanisms by which influenza 
A/WSN/33 activates HERV-W expression have not yet been resolved.  
 
A previous study reported up-regulation of mouse Gcm1 and syncytin B in vitro in 
embryo fibroblast cell line (NIH-3T3) and primary cultures of neurons or glia cells, as 
well as increased levels of Gcm1 transcripts in vivo in brains of mice, following 
influenza A virus infection (Asp et al., 2007). To what extent the expression of GCM1 
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is involved in the transactivation of ERVWE1 in response to virus infection in human 
non-placental cells has not been investigated. 
 
Efficient splicing of ERVWE1 transcripts has been reported in placental cells, where the 
ratio of spliced to nonspliced transcripts is 6:1. In comparison, undetectable spliced 
transcripts and very low levels of nonspliced transcripts have been observed in non-
placental cells (Trejbalova et al., 2011). The influence of virus infection on the 
ERVWE1 splicing has not been investigated previously. 
 
Hypermethylation and H3K9me3 on the ERVWE1 promoter play critical roles in the 
suppression of ERVWE1 as described above. Modification of the methylation status of 
host DNA has been observed in response to DNA viruses (Esteki-Zadeh et al., 2012; 
Macnab et al., 1988; Ryan et al., 2010; Vivekanandan et al., 2010), as well as in 
response to influenza A virus infection (Li et al., 2010; Tang et al., 2011) in different 
cell-lines. Histone modifications such as acetylation and methylation induced by DNA 
viruses have also been observed following infection of tumor cells (Iseki et al., 2005; 
Tian et al., 2013). If virus infection affect DNA methylation and/or chromatin 
modifications, and thereby induce up-regulation of HERV-W, especially the ERVWE1 
locus, in non-placental cells remain uncharacterized. 
 
Virus encoded proteins could be potential factors involved in the gene regulation by 
interacting with histones. The influenza A virus-encoded protein, NS1, was reported to 
interfere with host gene transcription at many different levels (Hale et al., 2008). For 
example, NS1 was recently reported to affect transcription of antiviral genes selectively 
through a histone mimic (Marazzi et al., 2012). Viral proteins NP, M1 and the vRNP 
(see Table 1 mentioned above) have been found to bind to different histone regions 
(Zhirnov and Klenk, 1997). Interestingly, NP was recently observed to co-localize with 
H3K9me3 in transcriptionally repressed regions (Alfonso et al., 2011). If viral proteins 
play a role on the transactivation of HERV-W is not known. 
 
1.6 ASSOCIATION BETWEEN HERV-W AND DISEASE  
1.6.1 Cancer 
An increasing body of evidence has demonstrated abnormal expression of HERV-W in 
cancerous cells. Up-regulation of HERV-W transcripts was detected in malignant 
tissues, such as testicular (Gimenez et al., 2010) and ovarian carcinoma (Menendez et 
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al., 2004). Correspondingly, global demethylation of HERV-W LTRs was observed in 
tumoral samples as compared to normal tissues, suggesting a correlation between 
HERV-W transcriptional capacity and CpG methylation control. Aberrant expression 
of syncytin-1 has also been observed in tumoral samples from breast cancer 
(Bjerregaard et al., 2006) and endometrial carcinoma (EnCa) (Strick et al., 2007). It has 
been reported that syncytin-1 play a functional role in the fusion process between breast 
cancer cell lines and endothelial cells (Bjerregaard et al., 2006). Furthermore, syncytin-
1 is involved in the fusion or the proliferation of EnCa depending on cAMP pathway 
activation or steroid hormone stimulation, respectively. The switch of syncytin-1 
function from fusion to cell differentiation appears to be regulated by transforming 
growth factor (TGF-β). Steroid hormone stimulates expression of syncytin-1 and TGF-
β which leads to cell proliferation. Up-regulation of syncytin-1, however, induces cell 
fusion in the absence of TGF-β (Strick et al., 2007). The over-expression of syncytin-1 
in EnCa could be a result of hypomethylation of 5' LTR, including the ERE and CRE 
(see Transcription factors mentioned above) binding sites (Strissel et al., 2012). Recent 
publications also indicates a significantly increased transcription of HERV-W in 
mycosis fungoides (cutaneous T-cell lymphoma) biopsies (Maliniemi et al., 2013) and 
specific detection of syncytin-1 in blood samples from patient with lymphoma and 
leukemia (Sun et al., 2010). 
 
1.6.2 Abnormal placentation 
Pre-eclampsia (PE), hemolysis elevated liver low platelets (HELLP) and intrauterine 
growth restriction (IUGR) are multisystem disorders during pregnancy associated with 
placental abnormalities. Hypoxia has been demonstrated to reduce the expression levels 
of syncytin-1 in PE (Kudo et al., 2003). Previous study reported decreased expression 
of GCM1 in PE (Chen et al., 2004). Hypoxia has also been considered to be involved in 
the down-regulation of GCM1 (Chiang et al., 2009). In all three syndromes, reduced 
expression of syncytin-1 (Ruebner et al., 2013) has been observed to coincide with 
increased apoptosis rate as compared with control placentas (Langbein et al., 2008). A 
DNMT3a-mediated hypermethylation of the promoter of ERVW1 has been suggested to 
be responsible for its decreased activities (Ruebner et al., 2013). 
 
1.6.3 Multiple sclerosis 
Multiple sclerosis (MS) is a chronic, neuroinflammatory demyelinating disease of the 
CNS. The cause of MS is unknown; however, a leading hypothesis suggests that MS is 
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the result of exposure of genetically susceptible individuals to certain environmental 
factor(s) such as viral infections (Compston and Coles, 2002). MS-associated retrovirus 
(MSRV) has been found as retrovirus-like particles budding from leptomeningeal cells 
of MS patients (Perron et al., 1989). By using RT-PCR, the retroviral pol sequences, 
which resemble MSRV and exhibit highest RT activity, have been amplified and 
isolated from MS patients (Perron et al., 1997). The identification of MSRV 
subsequently allowed the identification of similar sequences, HERV-W, in the human 
genome. MSRV is proposed to be an exogenous replication-competent member of 
HERV-W (Perron et al., 1997), reviewed in (Dolei and Perron, 2009). A recent study 
however suggested that some of the MSRV sequences identified in patients are derived 
from template-switching between transcripts from dispersed genomic HERV-W loci 
during reverse transcription, i.e. an artifact occurring during complementary DNA 
(cDNA) synthesis (Laufer et al., 2009). Thus, the existence of an exogenous infectious 
retroviruses related to HERV-W remains to be firmly established. 
 
Transcription of HERV-W has previously been investigated in many MS-related 
studies which suggest that HERV-W expression may play important roles in MS 
development. Using qRT-PCR, increased levels of HERV-W env transcripts were 
observed in PBMC (Mameli et al., 2007a) and brains from patients with MS relative to 
control individuals (Antony et al., 2006; Antony et al., 2007b; Mameli et al., 2007a). 
The fact that HERV-W GAG and ENV proteins are expressed in the neuronal and glial 
cells, respectively, in the normal brains suggests a physiological function of HERV-W 
in human brain, while macrophage-specific detection of ENV expression from MS 
lesions indicates HERV-W is involved in the pathogenesis of MS (Perron et al., 2005). 
Whereas enhanced expression of syncytin-1 was reported in glial cells of MS lesions 
(Antony et al., 2004), down-regulation of the receptor ASCT1 was observed in 
demyelinated regions in the brains of MS patients (Antony et al., 2007a). In vitro 
studies of astrocytes indicated that syncytin-1 expression can be activated by pro-
inflammatory molecules such as tumor necrosis factor-alfa (TNF-α), interferon-gamma 
(IFN-γ), interleukin-6 (IL-6) and IL-1, but inhibited by anti-viral IFN-β (Mameli et al., 
2007b). TNF-α-stimulated syncytin-1 expression through enhancing the nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) binding to the NF-κB-
responsive element located in the upstream enhancer region (MaLR LTR) of ERVWE1 
promoter (Mameli et al., 2007b), over-expression of syncytin-1 in turn resulted in up-
regulation of pro-inflammatory cytokine IL-1β and oligodendrocyte cytotoxicity by 
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inducing release of redox reactants (Antony et al., 2004). Moreover, a distinct pathway 
implicated in MS pathogenesis was supported by the evidence that increased syncytin-1 
levels cause increased inducible nitric oxide (NO) synthase and concurrent suppression 
of hASCT1 through induction of old astrocytes specifically induced substance (OASIS, 
an endoplasmic reticulum stress sensor), leading to oligodendrocyte damage and 
demyelination (Antony et al., 2007a).  
 
1.6.4 Psychiatric disorders 
Psychiatric disorders such as depression, bipolar disorder and schizophrenia are serious 
mental diseases. It is believed that both genetic components and environmental factors 
contribute to these disorders, reviewed in (Torrey et al., 1997; Yolken and Torrey, 
1995). For example, exposures to various obstetric complications including pre-
eclampsia increase the risk for later developing schizophrenia (Dalman et al., 1999). 
Accumulating evidence suggests that maternal infections such as prenatal influenza, 
reviewed in (Brown and Derkits, 2010), HSV-2 (Mortensen et al., 2010), Toxoplasma 
gondii and cytomegalovirus (Blomstrom et al., 2012) infections are risk factors for 
schizophrenia. Influenza viral infection has also been associated with bipolar disorders 
based on epidemiological and serological evidences (Parboosing et al., 2013). 
Retroviruses have been proposed as potential infectious agents involved in the 
pathogenesis of schizophrenia, reviewed in (O'Reilly and Singh, 1996; Yolken et al., 
2000).  
 
During a RT-PCR based study of potential retroviral activity in schizophrenia 
employing degenerate primers directed at a conserved region of the RT, HERV-W pol 
RNA was found in cerebrospinal fluids (CSF) of 30% of patients experiencing their 
first-episode of schizophrenia or schizoaffective disorder. Moreover, differential up-
regulated transcription of HERV-W pol was detected in frontal cortex regions of 
postmortem brains from schizophrenic patients compared with controls (Karlsson et al., 
2001). Similar up-regulation of HERV-W env transcripts were more recently reported 
from blood samples of patients with recent-onset schizophrenia (Huang et al., 2011) or 
bipolar disorder in comparison with healthy controls (Perron et al., 2012). In addition, 
elevated levels of HERV-W gag sequences were detected in plasma and PBMC from 
patients with a recent diagnosis of schizophrenia, as compared with individual controls 
(Karlsson et al., 2004; Yao et al., 2007). Intriguingly, Perron and coworkers reported 
that HERV-W GAG and ENV protein are predominantly expressed in serum of 
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schizophrenic patients (Perron et al., 2008). Employing microarray chip assay, in 
contrast, HERV-W pol transcripts were detected at similar levels in brains from 
patients with schizophrenia or bipolar disorder and control individuals (Frank et al., 
2005).  
 
The primary cause(s) of the aberrant expression of HERV-W members observed in 
these different patients, and their potential role in the pathogenesis of these diseases is 
unclear. These observations suggest a potential link between exogenous infections-
driven, such as influenza virus infection-induced activation of HERV-W and 
psychiatric diseases. Further studies are required to improve our understanding of 
transcription and functional role of HERV-W play during these diseases which is 
important for the development of better treatment and prevention strategies. 
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2 AIMS 
 
The general aim of this thesis project was to investigate the transcription of genomic 
regions harboring HERV-W elements. The major specific aims are; 
 
            1. To investigate the extent and variation of transcription of HERV-W elements in 
human tissues with a particular focus on the variation between different human brain 
regions. 
            2. To determine if transcription of HERV-W elements, in different tissues and cells, 
is a consequence of transcriptional leakage, or specifically directed from the retroviral 
LTR, or both. 
            3. To address the mechanism underlying transactivation of HERV-W elements, 
especially the ERVWE1 locus, in response to exogenous influenza A/WSN/33 virus 
infection. 
           4. To characterize HERV expression in human brain regions using next generation 
sequencing.  
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3 METHODOLOGICAL CONSIDERATIONS 
Detailed information of the material and methods are provided in the individual 
papers. Here, the advantages and limitations of the methods are briefly discussed.  
 
3.1 CELL CULTURES 
For the purpose of investigating the effects of exogenous/environment stimuli on the 
expression of HERV-W in human cells, primary fibroblast cells were prepared by 
cutaneous biopsy. Since details of growth media and conditions of fibroblast cultures 
were not provided in the published three papers, the description see below. Fibroblast 
cells were cultured in regular DMEM GlutaMAX media with Penicillin/Streptomycin 
and 15% fetal bovine serum (FBS), supplemental with 10mM HEPES, 1× MEM amino 
acids, 1× sodium pyruvate which is designed for the growth of  these cells. Cell 
cultures were used after 2-3 passages. In addition, cell-lines originating from different 
tissue types were also used in this project. Human astrocytoma cell-line (CCF-STTG1), 
human neuroepithelioma cell-line (SK-N-MC, HTB-10), human lung epithelial cell-
line (A549) and human embryonic kidney cell-line (293A) were employed to model 
extra-placental cells. By comparison, human choriocarcinoma cell-line (JEG-3) was 
applied to examine the properties of placental trophoblast cells.  
 
Cell-lines are readily available and unlimited sources of biological material but are 
usually derived from tumor tissues and have adapted to growth in culture which may 
imply varied expression compared to a normal cell. In contrast, primary cells, such as 
dermal fibroblast, are better representing cells in vivo and thus able to generate more 
physiologically correct data, as well as addressing the role of genetic variation. The 
regional ethics committee has approved all the experiments regarding the primary cell 
culture (04-273/1, 2006/637-32 and 2009-06-12).   
 
3.2 TREATMENTS 
In order to study the expression alteration of HERV-W elements in response to stimuli 
treatment, here we investigate;  
3.2.1 Serum deprivation 
As an unspecific stressor, serum withdrawal commonly stimulates the cells to reduce 
their basal activity (Iyer et al., 1999). In paper I and III, human primary fibroblasts 
cultures and cell-line were subjected to serum starvation to examine the environmental 
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influence on expression pattern of HERV-W. Cells cultured in normal growth media 
were washed with corresponding growth media without fetal bovine serum (FBS) and 
incubated in serum deprived media for 24 hrs before harvest.   
 
3.2.2 Poly (cytidylic-inosinic) acid (Poly(I:C)) treatment 
The structure of poly (I:C) resembles double-stranded RNA (dsRNA). Therefore, in 
paper III poly (I:C) was used to elicit a cellular anti-viral response in CCF-STTG1 
cultures by simulating viral infections. The outcome was compared to that influenced 
by influenza A/WSN/33 virus infection. The cultured cells were harvested after 6~24 
hrs incubation. 
 
3.2.3 Influenza A/WSN/33 virus infection 
Influenza A/WSN/33 virus strain is a mouse adapted neurotropic strain and has been 
used to infect mouse brain cells, including both in vitro and in vivo, in our previous 
studies (Asp et al., 2007). HERV-W can be transactivated in human non-placental cells 
by influenza A/WSN/33 virus infection (Nellaker et al., 2006), in paper II and III this 
virus was applied to investigate the effects of virus infection on the expression and 
regulation of HERV-W and reveal the mechanism of transactivation of HERV-W 
following virus infection in cell-types mentioned in section 3.1 above. Cell cultures 
were washed with Minimum Essential Media and then infected with influenza virus at 
different multiples of infection (MOI) depending on the purpose of the experiment 
(usually at 0.5 MOI, i.e. ratio of virus particles to cells is 1:2). After 1 hour of virus 
adsorption in serum-free media, cells were rinsed and kept in complete growth media 
and harvested after 6~48 hrs incubation. 
 
3.3 Q-RT-PCR 
To investigate HERV-W transcription in the human genome, the amount of expressed 
element in a cell can be measured by the number of corresponding mRNA transcript 
copies present in a sample. For mRNA-based PCR the RNA population is first isolated 
and reverse transcribed to cDNA. Total RNA from most material such as cells and 
tissues were prepared with Qiagen RNeasy Mini Kit. To avoid the risk of the 
hemoglobin interfering with the affinity column, Qiazol Kit was used in combination 
with RNeasy Mini Kit to extract RNA from whole blood samples. Purified RNA was 
quantified by using a Picodrop Microliter UV/Vis spectrophotometer and a fixed 
amount of RNA was treated with DNase I (Invitrogen) to remove any residual genomic 
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DNA. RNA was then converted to cDNA using reverse transcriptase Superscript II and 
oligo (dT) primers (Invitrogen) primarily targeting poly-adenylated mRNAs.   
 
The PCR, an indispensable tool commonly used in medical and biological research 
nowadays, was developed in 1980’s (Mullis et al., 1986). This technique consists of a 
predetermined number of cycles with repeated temperature changes, each cycle 
normally consist of denaturation, annealing and extension steps. As PCR progresses, a 
small amount of specific DNA sequence is selectively amplified by using two primers 
that are complementary to the target sequence, deoxribonucleotide triphosphate (dNTP) 
and thermo stable Taq DNA polymerase. The amount of amplicon is doubled for every 
completed cycle and the final product at the end point can be visualized by agarose gel 
electrophoresis and staining with ethidium bromide, Gel-Red etc. The method was used 
in paper III.  
 
Quantitative PCR (Q-PCR, also called real-time PCR) follows the general principle of 
conventional PCR but simultaneously detects and measures target sequence as the 
reaction progresses in "real time" which therefore provides more rapid and sensitive 
results over a far wider dynamic range than end-point analysis by electrophoresis. 
SYBR green and TaqMan, generating a fluorescence signal during the amplification, 
are the two most often used methods in qPCR. The latter requires the additional design 
and synthesis of a specific probe to monitor the amount of amplicons. To be more 
convenient and economic we applied SYBR green as an intercalating dye reporter in 
this study, bearing in mind its potential binding to non-specific dsDNA PCR products 
that may interfere with quantification of the target sequence. Application of SYBR 
green in qPCR requires identification of specific amplicons using analysis of their 
melting temperature (Tm) in a post-amplification dissociation step. Accurate results can 
be achieved by comparing the dissociation curves of the analyzed products. 
 
Q-RT-PCR is widely used in the relative and absolute quantification of gene 
expression. Threshold, an arbitrary level of fluorescence, is chosen on the basis of the 
baseline variability. In this plot model, a signal detected above the threshold is defined 
as the threshold cycle (Ct) for a sample. The relative levels of target sequence between 
samples can then be acquired by comparing their Ct value to those of an endogenous 
reference. The expression of reference, often using “house keeping” gene such as 
GAPDH, β-actin, rRNA etc., is assumed to be constant across different tissues and 
 22 
different experimental conditions. However, it is difficult to set an appropriate internal 
control when comparing between different tissues or treatments. For example, virus 
infections cause instability of cellular genomic material and altered expression of a 
large number of cellular genes. As the viral replication proceeding, total amount of 
RNA from viruses and host genes largely varies in the infected cells. Although no 
reference is optimal, in this thesis relative expression of HERV-W elements were 
arbitrarily normalized to β-actin transcripts in experiments encompassing different 
tissues and cell-lines. The ∆Ct denoted as difference between target gene and β-actin Ct 
values in each sample is obtained by Ct target - Ct β-actin. The ∆∆Ct denoted as difference 
between the ∆Cts in treatment groups is then obtained by ∆Ct treated - ∆Ct untreated. 
Ultimately, fold differences in the levels of transcripts among groups is calculated by 
using the formula 2-∆∆Ct (Livak and Schmittgen, 2001). In theory, this formula is 
applicable only when the reaction efficiency in an ideal PCR is 100%, which generates 
a doubling of the amount of amplicon every cycle. Differing efficiencies between the 
control and target gene leads to exponentially growing errors in the final fold 
calculation. In paper II, efficiency of each assay was determined by using E=10-1/slope-1. 
Efficiencies of the assays designed for HERV-W elements and those of the assays 
designed for adjacent genes were equal. Hence, this equality enables the base “2” in the 
formula described above to suffice the calculation of fold change. The qPCR 
technology was used in paper I-III. 
 
3.4 MELTING TEMPERATURE (TM) ANALYSIS 
As described above, SYBR green chemistry is applied in qPCR based on the specific 
Tm of amplified fragment. The Tm measured in the dissociation stage is used to detect 
erroneous product and sequence variation between amplicons. Tm analysis has 
previously been used to identify the expression patterns of HERV-W gag and env 
elements (Nellaker et al., 2006). By this technique qPCR amplicons can be classified 
into distinct melting temperature ranges indicating sequence differences and thus 
transcripts from different genomic loci can be identified. A novel technique “high 
resolution Tm analysis” was subsequently developed by employing an additional 
molecular beacon as an internal control for temperature variations over the heat-block 
during the dissociation step (Nellaker et al., 2008; Nellaker et al., 2007). In 
denaturation step, the fluorescence of the molecular beacon increases on melting which 
generate dissociation curves distinguishable from that of SYBR products. In addition, 
the tool, Gaussian curve fit analysis of Tm (GcTm) program, is applied to determine 
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more precise and unbiased Tms of amplicons, Figure 4. By using the Tm-probe in 
combination with the curve-fit method, Tm resolution can be improved up to 3-fold and 
errors introduced by the instrument is eliminated to some extent. Furthermore, this 
technique allows additional melting temperature to be identified. In paper I-III, this 
approach was applied to examine the frequency distribution of HERV-W gag sequence 
across human tissues and individuals, along with the distribution variation in response 
to stress treatments including virus infection. The Tm analysis program presented in 
three papers was adapted for the ABI Prism 7000 SDS instrument but the principles can 
be adapted to other systems. 
 
 
Figure 4 Distribution of reported temperatures over a 96-well plate in an ABI Prism 7000 for 1 
template sequence. Top, one example of the Tms reported by the SDS software. Upper middle, indicates 
the amplicon Tms reported by SYBR and calculated by the Tm-analysis program. Lower middle, Tm-probe 
Tms as calculated by GcTm Tm-analysis program. Bottom, the normalized Tms of the amplicons, (i.e., 
calculated Tms corrected for temperature variations with the Tm-probe data). The lower 3 plots represent 
data averaged for 3 dissociation curves. (Christoffer Nellåker, Ulf Wållgren, and Håkan Karlsson. 
Molecular Beacon–Based Temperature Control and Automated Analyses for Improved Resolution of 
Melting Temperature Analysis Using SYBR I Green Chemistry. Clinical Chemistry 2007; v. 53, p.98-103. 
Figure reproduced with permission from the American Association for Clinical Chemistry). 
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3.5 PLASMID EXPRESSION SYSTEM AND TRANSFECTION 
To investigate if over-expression of GCM1 regulates transcription of ERVWE1 in 
paper III, CCF-STTG1 or JEG-3 cells were transfected with plasmid construct 
pcDNA3.1/V5-HIS-TOPO containing full length of ORF encoding human GCM1 
using Lipofectamine 2000 in accordance with the manufacturer’s instructions 
(Invitrogen). Transcription of insert GCM1 in the plasmid can be induced through the 
strong CMV promoter. Since an 80% similarity, specially a highly evolutionarily 
conserved “gcm motif”, has been shared by homologous GCM1 genes from human and 
mouse, this plasmid was previously used in the studies of examining the influence of 
Gcm1 on syncytin A and syncytin B, analogs for human syncytin-1, in murine cells 
(Asp et al., 2007).  
 
3.6 RNA INTERFERENCE 
RNA interference (RNAi) is terms describing a conserved biological response to 
complementary dsRNA which mediates resistance to parasitic nucleotide sequences 
and represses gene expression. In non-mammalian systems such as C.elegans and 
Drosophila long dsRNA is routinely used for the specific suppression of genes. 
However, in mammalian cells introduction of dsRNA molecules longer than 30 nt may 
trigger potent antiviral response, thereby leading to global changes of gene expression. 
In this thesis chemically synthesized small interfering RNA (siRNA), comprised of 21-
mer dsRNAs which targeted to specific sequence of GCM1, was used to perform gene 
silencing experiment. Transfection was carried out in CCF-STTG1 or JEG-3 cells using 
HiPerFect (Qiagen) according to the manufacturer's instructions in paper III. 
 
3.7 PYROSEQUENCING  
The bisulfite reaction, deaminating cytosine residues through sodium bisulfite 
treatment, was discovered in 1970’s (Hayatsu et al., 1970) and developed in 1990’s to 
analyze 5-methylcytosine (5mC) in DNA (Frommer et al., 1992). For ERVWE1 
promoter-specific methylation analysis in paper III, cytosine was first converted to 
thymine in single strand DNA of genomic DNA from cell cultures after sodium 
bisulfite treatment, while 5mC remains unaffected. Using primers specific designed for 
bisulfite modified DNA, the DNA sequence of interest was amplified by conventional 
PCR. Unique amplicon was loaded in the following pyrosequencing reaction. 
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Developed in 1996, pyrosequencing is a technique of DNA sequencing based on the 
"sequencing by synthesis", (Ronaghi et al., 1998). In principle, the specific sequencing 
primer hybridizes with a single-stranded PCR product followed by incorporation of 
dNTP into DNA strand. Nucleotide incorporation generates light seen as a signal peak 
in the program trace. Unincorporated nucleotides are subsequently degraded and 
addition of dNTPs is performed sequentially which determine the strand sequence. 
Compared to conventional sequencing of plasmid clones with insert of interest, this 
technique is fast, simple to use to delivery real sequence data with high accuracy and 
quantity. This protocol has been reported to detect DNA methylation differences as 
small as 5% (Colella et al., 2003).  
 
3.8 CHROMATIN IMMUNOPRECIPITATION 
Chromatin immunoprecipitation (ChIP) assay is a powerful technique for 
characterizing the association of genomic DNA sequences with specific regulatory 
proteins. There are mainly two typical ChIP; cross-linked ChIP (XChIP) and native 
ChIP (NChIP). The former method was established in Bacterial research and developed 
in the field of Drosophila in the 1980’s (Jackson, 1978; Solomon et al., 1988) and 
extensively refined thereafter. This method is widely used in living organisms and cell 
culture. In paper III, XChIP was used to investigate the levels of H3K9me3, SETDB1 
and influenza A viral proteins in CCF-STTG1 cells. Typically, in ChIP DNA-protein 
complexes are cross-linked and then sheared. Associated DNA fragments are 
selectively immunoprecipitated by specific antibody, purified and amplified for the 
target gene analysis using real time PCR or next generation sequencing (NGS). 
 
3.9 RNA SEQUENCING 
By using NGS, RNA sequencing is a technology to quantitatively analyze entire 
transcriptomes. NGS is vigorously developed in recent years, generating high 
throughput sequencing data which can be used to identify expressed transcripts in a 
wide range of research (Chu and Corey, 2012). Basically, RNA is first extracted from 
samples, followed by reverse transcription. Optional fragmentation before reverse 
transcription may decrease the 5’ bias of randomly primed-reverse transcription and the 
possibility of primer binding sites affected by secondary structures. Synthesized cDNA 
can be fragmented via size selection and then subject to the sequencing. For different 
purposes, mRNA can be preselected by poly-A enrichment or rRNA depletion during 
their isolation from total RNA. In paper IV, a publicly available RNA sequencing 
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datasets produced from human postmortem brain tissues (can be requested at 
http://sncid.stanleyresearch.org/) were used to investigate transcription of HERV 
repetitive sequences. 475 individual consensus sequences representing LTR repeats 
were downloaded from Repbase at www.girinst.org/repbase. These are the same 
sequences that are used by RepeatMasker to annotate repeats in sequenced genomes 
(Jurka, 2000). The consensus sequences were imported into CLC Genomics 
Workbench 5. This software were subsequently used for alignment of sequence reads to 
the consensus sequences allowing only unique matches using the following settings; 
similarity: 0.9, length fraction: 0.9, insertion cost: 3, deletion cost: 3, mismatch cost: 2. 
Reads were also aligned to the human genome (Hg19) using the same settings but 
including reads with multiple hits (randomly assigned) to obtain a measure of the 
proportion of mappable reads in each of the libraries. 
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4 RESULTS AND DISCUSSION 
4.1 EXPRESSION PATTERN OF HERV-W GAG TRANSCTIPTS 
The repetitive nature of HERV-W has lead to difficulties in identifying single elements 
due to methodological limitations, and hence little is known of the extent of expression 
of individual elements. Using high-resolution Tm analysis (see section 3.4 above) in 
paper I we examined the frequency distribution of transcripts containing HERV-W 
gag sequences in a wide range of human tissues and cells, including testis, ovary, 
thymus, PBMC, placenta, liver, blood, spleen and regions of the brain, as well as in 
human primary fibroblast cultures. A total 2775 indistinguishable Tm observations 
from these tissue samples were stratified into 13 categories to construct optimal mixture 
models according to Akaike’s information criterion. From the profiles data, there were 
significant differing patterns of HERV-W gag transcripts between all the tissues 
investigated. Of these tissues, thymus and testis exhibited the most distinct expression 
patterns. Expression of such transcripts also differed between ten regions of the brain. 
The blood samples from different individuals, however, presented a far more 
homogeneous expression pattern of HERV-W gag transcripts. In addition to the tissue-
specific expression pattern of HERV-W gag, expression of such transcripts varied more 
between individuals in cerebellum and four cortical regions of brain than in other 
tissues (spleen, blood and skin fibroblast).  
 
Dendrograms based on gene expression patterns has been previously built from 
numerous human tissues (Shyamsundar et al., 2005). Similarly, our dendrogram, 
constructed on the basis of neighbor-joining of the Pearson correlation coefficients, 
grouped brain regions and gonads together and tissues rich in cells of the immune 
system together. Although insufficient data only provided inferring phylogenies, these 
results indicated that HERV-W gag transcripts vary between tissues in a similar way to 
that of coding transcripts and suggested an extensive and patterned transcription of 
HERV-W elements.  
 
Analyses of primary fibroblast cultures from separate individuals avoid potential 
artifacts introduced by cell composition and dissection. In addition to determine tissues-
specific and inter-individual varied patterns of expression, we used this approach to 
investigate the effect of exogenous stimuli on the expression pattern of HERV-W gag 
transcripts. Indeed, variation levels of expression patterns in fibroblast cultures were 
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reduced in response to serum deprivation. Further investigation, using the same Tm 
analysis, revealed significant qualitative variations of HERV-W gag transcripts in 
fibroblast cultures following influenza A/WSN/33 virus infection (paper II and III). 
In line with the changes in response to serum deprivation, the varied distribution pattern 
of HERV-W gag sequences detected in uninfected cultures became more homogenous 
in virus infected cultures.  
 
Taken together, HERV-W gag transcripts appeared to exhibit a highly diversified 
expression pattern across both tissues and individuals. The Tm analysis provides a 
cheap and rapid approach to investigate changes of distribution patterns of HERV-W 
gag in response to environmental stimuli. 
 
4.2 TRANSCRIPTION OF INDIVIDUAL HERV-W ELEMENTS      
Although the method (applied in paper I) revealed a non-random expression pattern of 
HERV-W elements, the mechanisms underlying their transcription remains 
uncharacterized. Pseudoelements, LINE-1-mediated retrotransposition of proviral 
elements, and truncated elements are considered as transcriptionally silent due to loss 
of U3 region of LTR (Costas, 2002; Pavlicek et al., 2002). Our previous studies, 
however, indicated expressed sequences that mapped not only to proviral elements, but 
also to pseudoelements and truncated elements which raised questions regarding the 
transcriptional control of these loci (Nellaker et al., 2006; Yao et al., 2007). In paper 
II, we therefore investigated the transcriptional regulation of individual HERV-W 
elements representative of three classes; proviruses, pseudoelements and solo LTRs.  
Due to the absence of entire LTR, truncated elements were not included. 
 
4.2.1 Distribution of HERV-W 
Using the HERV17 internal sequence or the LTR17 sequence from Repbase Update 
(Jurka, 2000) followed by manual inspection of fragmental loci, we identified 295 
HERV-W loci by BLAT searches (Kent, 2002) of the human genome (March 2006 
assembly), see Table 2. Loci were defined as intronic if located within the boundaries 
of annotated RefSeq genes (Pruitt et al., 2007). Along with the gene distribution 
through the human genome, approximately 28% HERV-W elements are located in 
intronic regions of annotated genes which is consistent with previous finding that most 
HERV families are more likely to be found in intergenic than in intronic regions (van 
de Lagemaat et al., 2006). Similar percentage of integrations in intronic regions are 
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observed in all the proviral elements (contain the regulatory U3 region of LTR), 
pseudoelements and solo LTRs (formed by homologous recombination) studied, 
suggesting that machineries of both LINE retrotransposition and homologous 
recombinations are neutral with regard to genic or intergenic regions. Intronic HERV 
members exhibited an anti-sense insertion preference (van de Lagemaat et al., 2006). It 
appears that pseudoelements drive the anti-sense bias integration of HERV-W intronic 
elements since proviruses and solo LTRs were not significantly biased.  
 
Table 2. Distribution of HERV-W elements 
 Proviruses Solo LTRs Pseudoelements 
Intergenic 37 110 66 
Intronic 10 43 29 
p-value  0.508 a  
 
 Total1 Expected* Pro Solo Total2 Expected* Pse Expected* 
Sense 21 43 3 16 19 28 2 14 
Anti-sense 65 43 7 31 38 29 27 15 
p-value 0.0005a 1.000b 0.087a 0.0008b  
 
Distribution of three categories of HERV-W elements in genic/intergenic regions and distribution of intronic 
HERV-W elements on sense and anti-sense strands, respectively. 1Total number of intronic HERV-W 
elements, 2 indicates number of proviruses and solo LTRs. * indicate expected number based on random 
integration (i.e. 50% on each strand). Pro, solo and pse indicate proviruses, solo LTRs and 
pseudoelements, respectively. a Chi-square test, b Fisher’s exact test. P-values <0.05 were considered 
significant. (Table reproduced from “Li F, Nellåker C,Yolken RH and Karlsson H. A systematic evaluation 
of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC 
Genomics. 2011”) 
 
4.2.2 Impacts of genomic context, viral structure and orientation on 
expression of HERV-W 
Next we designed assays specific for a number of intronic and intergenic HERV-W 
elements with or without intact regulatory regions as well as for their corresponding 
flanking genes, as illustrated in Figure 5. By using qPCR, we measured the expression 
levels of these elements in various human tissues and subsequently examined the 
influence of genomic context, viral structure and orientation on their expression. 
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Figure 5 Strategy for design of assays specific for intronic and intergenic HERV-W elements and their 
corresponding genes. F3’/R3’ and F5’/R5’ denote forward and reverse primers in intronic regions 3’ and 5’ 
of HERV-W elements, respectively. (Figure modified from “Li F, Nellåker C,Yolken RH and Karlsson H. A 
systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure 
and orientation. BMC Genomics. 2011”) 
 
According to our data, all the HERV-W elements investigated are expressed in the 
tissues analyzed despite quantitative variation across individual tissues and elements, in 
line with previous studies of widespread expression of HERV-W elements in human 
cells (Nellaker et al., 2006; Yi et al., 2004) and tissues (Laufer et al., 2009; Yao et al., 
2007). HERV-W elements in intronic regions were expressed at higher levels (i.e. 
lower Ct value) than elements in intergenic regions. It has also been observed that 
HERV-K LTRs in gene-rich regions exhibit significantly higher activities than those in 
gene-poor regions (Buzdin et al., 2006), suggesting an influence of genomic context on 
the transcriptional activity. Regarding the intronic elements, proviral elements 
exhibited higher expression levels than pseudoelements regardless of the transcriptional 
activities of the genes into which they are integrated, indicating the functional promoter 
activity of the U3 region in the proviral LTR. Indeed, such LTRs in the HERV-W and 
other families are active in different human cells to initiate transcription of HERV 
elements (Buzdin et al., 2006; Schon et al., 2001), or act as alternative promoters which 
modulate transcription of nearby genes (Conley et al., 2008; Gogvadze et al., 2009; 
Khodosevich et al., 2002), reviewed in(Griffiths, 2001). Proviral elements, particularly 
those with only one intact LTR, were detected at significantly higher levels than those 
of solo LTRs, suggests an involvement of internal sequence (i.e. gag, pol and/or env) in 
the expression of transcripts generated which might be due to an effect of regulatory 
element located in the internal sequence (Buzdin et al., 2006) (Figure 6).  
 
Relative to their corresponding genes, intronic elements integrated on the sense strand 
appeared to be transcribed at higher levels than those integrated on the anti-sense 
strand. Furthermore, linear regression analyses suggest that expression of transcripts 
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containing intronic proviral elements is independent from that of their corresponding 
genes. In contrast, intronic pseudoelements are highly correlated to their corresponding 
gene transcripts and therefore appear to represent unprocessed pre-mRNAs or leaky 
transcription of coding genes. 
 
                       
Figure 6 Comparison of average expression levels between intronic (n = 14) and intergenic (n = 10) 
HERV-W elements in eight human tissues (A). Comparison of expression levels between proviral (n = 7) 
and pseudoelements (n = 7), as well as comparison of expression levels between the genes into which 
these elements are integrated (B). Expression Levels of proviral elements and solo LTRs (n = 6) (C). Low 
ct value indicates high expression. Bars indicate means and error bars indicate SD. Statistical significance 
is indicated by *= p0.05, **= p0.01, ***= p0.001. (Figure modified from “Li F, Nellåker C,Yolken RH and 
Karlsson H. A systematic evaluation of expression of HERV-W elements; influence of genomic context, 
viral structure and orientation. BMC Genomics. 2011”) 
 
Taken together, these findings suggest that our previously observed diversified and 
tissue-specific expression of elements in the HERV-W family is the result of both 
directed transcription (involving both the LTR and internal sequence) and leaky 
transcription of HERV-W elements in normal human tissues. 
 
4.3 TRANSACTIVATION OF HERV-W      
4.3.1 Effects of exogenous stimuli on the HERV-W promoter/LTR 
In addition to the alterations in expression pattern of HERV-W gag sequence in 
primary fibroblast cultures in response to serum deprivation or influenza A/WSN/33 
virus infection, significant quantitative up-regulation of HERV-W gag transcripts was 
also detected in virus-infected cultures (paper II-III), which expands our previous 
study of transactivation of HERV-W elements by cellular stress or virus infection in 
non-placental cell-lines (Nellaker et al., 2006). In paper II, we investigated effects of 
virus infection on the expression regulation of individual HERV-W elements in 
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fibroblast cells. Unlike pseudoelements, proviral elements displayed significantly 
elevated transcriptional activities following virus infection relative to their 
corresponding coding transcripts, further supporting independent and regulated 
expression of proviral elements.  
 
Interestingly, the distribution pattern of HERV-W gag was very similar across 
individuals following virus infection, which exhibited an evident increase in one out of 
13 categories (paper III). Specific HERV-W loci from this category were isolated and 
identified, one of which corresponds to a proviral elements investigated in paper II. 
This proviral element (chr6p22.2) is located in the intronic region of ACOT13 and is 
expressed at significantly higher levels in virus infected fibroblast cells, suggesting an 
important and consistent role for the LTR of HERV-W in regulating transcription of 
proviral genome across multiple individuals. 
 
Therefore, exogenous influenza A virus can promote transcription of members of the 
HERV-W family, including an intronic proviral element in ACOT13, in both non-
placental cell-lines and primary fibroblast cultures. 
 
4.3.2 Transactivation of ERVWE1 by influenza A/WSN/33 virus infection     
In contrast to most HERV-W loci, the promoter region in the ERVWE1 locus has been 
investigated in great detail (Bonnaud et al., 2005; Cheng et al., 2004; Prudhomme et al., 
2004). This locus encodes syncytin-1 (Voisset et al., 2000), the only known HERV-W 
gene known to be functionally adopted by the human host (Kim et al., 1999). We 
previously reported that ERVWE1 can be induced in extra-placental cell-types in 
response to influenza A/WSN/33 virus infection by unidentified mechanisms (Nellaker 
et al., 2006). In paper III, we investigated potential factors that might contribute to the 
transactivation of ERVWE1 in non-placental cells following virus infection. 
 
Previous studies have revealed synergistic effect of 5’LTR and upstream TSE region on 
the promoter activity of ERVWE1 (Prudhomme et al., 2004). The transcription factor 
GCM1, can bind to the TSE region and plays an important role in regulating its 
expression (Nait-Oumesmar et al., 2000; Yu et al., 2002). We detected inducible 
expression of both ERVWE1 and GCM1 in transformed malignant astrocytoma cell-line 
(CCF-STTG1 cells) and primary fibroblasts following influenza A/WSN/33 virus 
infection. These observations complement a previous report of up-regulation of mouse 
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Gcm1 following influenza A virus infection both in vitro and in vivo (Asp et al., 2007). 
However, studies by us and other indicate that over-expression of GCM1 is insufficient 
to induce transcription of ERVWE1 in non-placenta cell-lines (Yu et al., 2002). On the 
other hand, siRNA analyses indicates that knock-down of GCM1 followed by virus 
infection suppress induction of transcription of ERVWE1, suggesting that GCM1 is 
required for the virus-driven transactivation of ERVWE1. Reductions of GCM1 and 
ERVWE1 transcripts do not affect levels of influenza RNA suggesting that these two 
genes are not critically involved in viral replication or in the host-cell defense to 
influenza A virus (Figure 7). GCM1 is thus involved in the physiological expression of 
ERVWE1 in placenta-derived tissue, and the ectopic expression in other cell types. 
 
                        
Figure 7 Transcription of ERVWE1 and GCM1 in response to virus infection. (A) Relative levels of 
ERVWE1 transcripts (env exon transcripts) and transcripts encoding GCM1 were measured in uninfected 
and influenza A/WSN/33 virus-infected (MOI=0.5) CCF-STTG1 cells at 24 h postinfection, primary human 
fibroblasts at 48 h postinfection, and JEG-3 cells at 24 h postinfection. (B) Levels of ERVWE1 and GCM1 
transcripts in CCF-STTG1 cells treated with siRNA targeted against transcripts encoding GCM1 and 
subsequently infected with influenza A/WSN/33 virus for 24 h relative to those in cells treated with control 
siRNA and infected with influenza A/WSN/33 virus. (C) Relative levels of transcripts encoding segment 8 
of the influenza A/WSN/33 virus in CCF-STTG1 cells treated with scrambled control siRNA or no siRNA 
reagents and in cells treated with siRNA targeted against transcripts encoding GCM1. siRNA analyses 
data are presented as means ± SEM from four independent experiments. *, p<0.05; **, p < 0.01, ***, p < 
0.001. (J Virol 2014; 88(8):4328-4337. doi: 10.1128/JVI.03628-13. FIG2. Figure reproduced with 
permission from American Society for Microbiology) 
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With regard to splicing of transcripts from ERVWE1, we demonstrated that the up-
regulation of ERVWE1 in response to a virus infection in non-placental cells appears 
to primarily result from increased generation of spliced transcripts. Kinetic analyses 
suggest that influenza A virus replication rather than the cellular stress response to 
starvation or the antiviral response to double-stranded RNA leads to increased levels 
of spliced transcript. The potential role of virus proteins in the transactivation of 
ERVWE1 is further supported by the ChIP assays, see below. The fusogenic protein 
syncytin-1 encoded by ERVWE1 spliced transcripts, exclusively expressed in the 
human placenta (Kim et al., 1999; Mi et al., 2000; Voisset et al., 2000), has been 
abnormally observed in diseases such as MS (Antony et al., 2007a; Antony et al., 
2004) and schizophrenia (Perron et al., 2008). In addition to the detection of induced 
spliced ERVWE1 transcripts by influenza A/WSN/33 virus infection in our study,  
several studies report transactivation of HERV-W, including syncytin-1, by EBV 
(Mameli et al., 2012) and HSV-1 infection (Nellaker et al., 2006; Ruprecht et al., 
2006). These infections have been associated with both MS (Giovannoni et al., 2006) 
and schizophrenia (Karlsson, 2003), but if they causally contribute to these disorders 
remains to be established. 
 
In addition to the impact of GCM1 on expression of ERVWE1, it has been reported 
that the high level of methylated CpGs in the 5’LTR and upstream TSE region of 
ERVWE1 in extra-placental tissues contribute to its restricted expression in the human 
placenta (Gimenez et al., 2009; Matouskova et al., 2006). Interestingly, mammalian 
GCM proteins have been recently reported to directly be involved in active CpG 
demethylation (Hitoshi et al., 2011). In light of the findings that an influenza A virus 
infection enhances host genes expression by demethylating their promoters (Li et al., 
2010; Tang et al., 2011), we next investigated the methylation status of 7 CpGs (see 
Figure 3) in the promoter and enhancer regions of ERVWE1. Pyrosequencing data 
indicate high methylation levels of these CpGs in a range of non-placenta cell-lines 
and fibroblast cultures, albeit with variation across 7 CpG sites. Comparably low 
methylation levels of two CpG sites (-32 or/and +86) of ERVWE1 promoter are in 
line with previous reports of partial methylation of the ERVWE1 enhancer-promoter 
region that did not completely silence promoter activity (Gimenez et al., 2009). 
However, no change in CpG methylation was observed in any of the cells following 
infection as compared to corresponding uninfected cells. 
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Figure 8. Histone H3K9me3 associated with HERV-W elements during influenza A virus infection. 
At 24 h postinfection, ChIP experiments were performed with rabbit IgG, antitrimethylated histone H3K9, 
H3 and SETDB1 antibodies on chromatin from uninfected and influenza A/WSN/33 virus-infected (MOI 
=0.5) CCF-STTG1 cells. Precipitated chromatin were determined by qPCR with specific assays for 
ERVWE1 (A) and solo LTRs integrated in intronic regions of ZNF277 and C9orf85 genes and 
proviruses  integrated in intronic regions of KYNU and ACOT13 genes (B). (C) Relative levels of 
transcripts encoding SETDB1 were measured in uninfected and virus-infected (MOI=0.5) CCF-STTG1 
cells at 24 h postinfection. (D) Levels of five HERV-W elements relative to levels of GAPDH in input 
chromatin and in chromatin immunoprecipitated with anti-influenza A/WSN/33 virus antiserum from 
virus-infected (MOI= 0.5) CCF-STTG1 cells. ChIP data are presented as means ± SEM from five 
independent experiments. *, p <0.05; ** p < 0.01. (J Virol 2014; 88(8):4328-4337. doi: 
10.1128/JVI.03628-13. FIG5. Figure reproduced with permission from American Society for 
Microbiology) 
 
Low transcriptional activity of ERVWE1 in Hela cells has previously been reported to 
associate with enrichment of a repressive histone mark H3K9me3 in the 5’ LTR 
region of this locus (Trejbalova et al., 2011). H3K9me2 and H3K9me3 have been 
reported to be critically involved in proviral silencing of ERVs in mESCs in a DNA 
methylation-independent manner, via H3K9-specific KMTase G9a and SETDB1 
respectively (Leung et al., 2011; Matsui et al., 2010). We subsequently examined 
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H3K9me3 deposits and SETDB1 occupancy in ERVWE1, along with relative levels 
of transcripts encoding SETDB1, in uninfected and virus-infected CCF-STTG1 cells. 
In addition to the detection of decreased SETDB1 transcription by qPCR, our ChIP 
assays detected reduced H3K9me3 and SETDB1 levels associated with increased 
transcription of ERVWE1 in infected cells, indicating that attenuation of SETDB1-
mediated H3K9me3 play an important role in the transactivation of ERVWE1 by 
influenza A virus infection. This correlation also applies to several other HERV-W 
loci including the intronic proviral element (chr6p22.2) studies in paper II, 
suggesting that the virus infection induces a global decrease in H3K9me3. 
Furthermore, influenza A viral protein are appeared to be more likely to bind to the 
HERV-W regions than to the GAPDH promoter, supporting previous finding that 
influenza encoded proteins co-localize with H3K9me3 tails during later stages of 
infection (Alfonso et al., 2011) (Figure 8). 
 
Taken together, an influenza A virus infection can induce transcription of ERVWE1, 
particularly spliced transcripts encoding syncytin-1, via de-repression of SETDB1-
mediated H3K9me3 on its LTR in concert with increased levels of GCM1 transcripts 
in CCF-STTG1 cells. 
 
4.4 DETECTION OF HERV BY RNA SEQUENCING 
Despite the observations of tissue-specific and patterned expression of HERV-W gag 
transcripts in paper I and regulated transcription of a number of individual HERV-W 
loci in paper II, the global expression of HERV is not well understood. In paper IV, 
we investigated the transcription of total HERV and the subfamilies HERV-W and 
HERV-H in particular, by analyzing publicly available RNA sequencing datasets 
generated from three regions of human brains; anterior cingulate cortex, hippocampus 
and orbitofrontal cortex, of multiple individuals.   
 
4.4.1 Extent of HERV transcription in genome 
In terms of the datasets, comparable 80~90% of total reads generated from each of 
three different brain regions aligned to the annotated human genome. Of all these reads, 
anterior cingulate cortex and hippocampus samples exhibited lower proportion of reads 
(25%) aligning to exon regions as compared to orbitofrontal cortex (75%) samples. The 
largest proportion of exons reads, concurrent with lowest proportion of intergenic reads 
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(13%) in the latter, is probably explained by differences in RNA and library preparation 
rather than biological differences between the three sequencing projects.  
 
It has been reported that HERV sequences make up 8% of the human genome (Belshaw 
et al., 2005). According to our analyses, approximately 0.1~0.2% of reads in all three 
brain regions aligned to the 475 HERV consensus sequences. This finding is in general 
agreement with notion that majority of HERV elements are not being transcribed or are 
expressed at low levels. Despite the lowest proportion (0.1%) of HERV elements, the 
detection in orbitofrontal cortex samples indicates that HERV is also expressed in a 
highly poly-A enriched fraction of RNA. Surprisingly, the average normalized 
expression levels of 475 different consensus sequences were highly correlated across 
the three regions (range R2 between 0.9472~0.9779) regardless of the differences 
observed between the libraries. The average normalized expression level for each 
consensus sequence as calculated based on a large numbers of reads obtained from 
multiple individuals for each dataset, the correlations therefore do not reflect intra-
individual difference or inter-individual differences in terms of transcribed loci within 
different families. 
 
4.4.2 Distribution of HERV in genome 
Based on the overall HERV expression across three brain regions, we attempted to 
examine transcription of individual loci of interest by mapping reads which aligned to 
the consensus sequences of HERV17_int, LTR17 and HERVH to the human genome. 
The HERV-H (HERVH) family contains a larger numbers of members, which 
increases the chance of two elements being identical and probably explains why a 
smaller proportion (44~75%) of the reads to be uniquely mapped in comparison with 
HERV-W (HERV17_int, LTR17) family (75~98%). In addition, compared to anterior 
cingulate cortex (75 bp) and hippocampus (50 bp) read lengths, the orbitofrontal cortex 
library consisted of longer read lengths (100 bp) which also allows larger proportion of 
the reads to be uniquely mapped.  
 
Next, we investigated the distribution of these repeat families across human 
chromosomes. From the mapping data, the proportion of reads which were uniquely 
mapped to each chromosome was not consistent with the proportion of integrated 
repeat sequences on each chromosome. This observation implies that some elements 
are relatively abundantly expressed whereas others are repressed. 
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Figure 9 Relative transcript levels of repeat elements in brain samples on chromosome 7. Left, 
positions of individual HERV17_int, LTR17 and HERVH loci on chromosome 7. Right, relative 
transcription of each locus from anterior cingulate cortex, hippocampus and orbitofrontal cortex is 
indicated by the height of the bars. Individual loci located in introns of annotated genes are indicated by 
an asterisk (*) to distinguish them from loci located in intergenic regions. 
 
To illustrate transcription of individual elements we mapped reads to individual loci 
along chromosome 7. Sixty-seven of HERV-W (i.e. 16 HERV17_int and 51 LTR 
loci) and sixty-two HERV-H loci, respectively, were identified to locate on 
chromosome 7. It is evident that not all elements in any one subfamily of repeats 
showed signs of expression. Moreover, the relative expression levels of certain loci 
might vary across three brain regions. In addition to intronic loci, several intergenic 
loci from both HERV-W and HERV-H families were expressed in three regions 
which in line with our previous study (Nellaker et al., 2006). Not only proviral 
elements but also psudoelements were expressed across different regions. This 
observation thus independently verifies our finding using locus-specific PCR in paper 
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II. A recent study using luciferase reporter assay reported promoter activity of HERV-
W with incomplete LTRs (Schmitt et al., 2013). We detected expression from 
partially fragmented LTRs of two psudoelements, which correspond to those 
integrated in the intronic regions of genes NRCAM and FOXP2 investigated in paper 
II, which further supports this finding. Of particular interest, the ERVWE1 locus in the 
HERV-W family exhibited the highest levels of expression in all brain regions 
(Figure 9).  
 
4.4.3 Transcription of HERV in disease states 
The three brain regions (anterior cingulate cortex, hippocampus and orbitofrontal 
cortex) investigated were obtained from patients with psychiatric diagnoses and control 
individuals. Therefore we took this opportunity to examine the normalized expression 
levels of HERV across different diagnostic groups in each region separately. In the 
investigated RNA sequencing data, an overall increased expression levels of HERV 
(475 consensus sequences) were observed in autopsied anterior cingulate cortex from 
not only schizophrenia but also bipolar patients compared to control individuals.  
 
Elevated levels of HERV-W transcripts were detected in anterior cingulate cortex from 
schizophrenia and in hippocampus from bipolar patients, confirming previous reports in 
postmortem brain tissues obtained by PCR (Karlsson et al., 2001) and extending these 
to include also bipolar disorder. Perron and coworkers reported similar findings in their 
recent studies conducted on blood samples (Perron et al., 2012). In addition to HERV-
W, HERV-H was expressed at increased levels in anterior cingulate cortex and 
hippocampus of schizophrenia suggesting that other repeat families are differentially 
expressed in schizophrenia.  
 
However, neither total HERV nor HERV-W and HERV-H families exhibited disease 
specific differences in orbitofrontal cortex libraries. Although these libraries were 
generated from the smallest number of individuals, they contain by far the largest 
number of reads per sample. Moreover, these libraries contain sequences representing 
exons mRNA which differ from anterior cingulate cortex and hippocampus libraries. 
Therefore, it is not clear if the lack of disease-related differences in the orbitofrontal 
cortex samples is caused by a lack of power or if these differences are detectable 
primarily in non-polyadenylated RNA. 
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Taken together, a consistent expression of HERV repetitive sequences can the detected 
by RNA sequencing in different brain regions regardless of the libraries preparation. 
This unbiased method can be used as a tool to investigate expression changes of HERV 
in disease states. 
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5 CONCLUDING REMARKS 
In this thesis, application of Tm analysis, without having to rely on expensive and time-
consuming sequencing, leads to a high resolution examination of the extent of 
transcripts originating from repetitive regions of HERV-W in various tissues and cell-
types, and of changes of such transcripts in response to exogenous cues. The method 
can be potentially used for determining detailed expression patterns of repetitive 
sequences in disease states. As this approach allows detection of variations in the 
sequence of a limited number of products within a Tm category of interest, the PCR 
directed at specific loci is useful for detection of transcription of individual elements. 
Employing such specific PCR, we investigated the expression levels of a number of 
members in HERV-W family and thus concluded that diversified expression of HERV-
W gag transcripts observed by Tm analysis comes from both LTR-directed 
transcription and transcriptional leakage. In light of the retained promoter activity in 
spite of U3 region lacking in the LTR, it appears that promoters from adjacent genes 
and also their own structurally incomplete LTRs contribute to the transcription 
initiation of psudoelements. Given the large number of HERV elements, RNA 
sequencing offers an unbiased technology to perform global analyses of HERV 
expression. A comprehensive understanding of extent of HERV repetitive sequences, 
especially of HERV-W and HERV-H families, in three different regions of human 
brains and disease states can be achieved from our analyzed sequencing data. Mapping 
of expressed sequences of HERV-W and HERV-H families to individual loci along 
chromosome 7 indicates active transcription of intronic and intergenic elements, as well 
as proviral elements and psudoelements, in general consistent with our observations 
investigated by PCR. Furthermore, elevated transcription of either total HERV or the 
W or the H family of HERV was observed in schizophrenia patients. Detection of 
HERV-W up-regulation in these patients supports previous similar findings based on 
PCR technique. Inasmuch as the three libraries were prepared under different protocols, 
these datasets might not be helpful for comparing expression levels of HERV sequence 
between brain regions. 
 
In addition to characterize the extent of transcription of HERV-W, experimental studies 
were carried out to elucidate the mechanism by which influenza A/WSN/33 activates 
HERV-W elements, in particular the ERVWE1 locus. Increased transcription levels of 
HERV-W members including ERVWE1 were detected not only in immortalized cell-
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lines, but also in primary fibroblast cultures of non-placental origin. In terms of our 
data, transactivation of ERVWE1 in these cells in response to influenza A virus 
infection appears to be attributed to several mechanisms; increased levels of 
transcription factor GCM1 transcripts, enhanced splicing strategy of ERVWE1, 
attenuation of H3K9me3 deposits on the ERVWE1 promoter, yet the role of influenza 
viral proteins and other unknown factors is still unclear. H3K9me3 reduction is also 
associated with de-repression of other HERV-W elements during virus infections. 
Considering the fact that hypomethylation correlates to reactivation of a range of 
HERV members, involvement of demethylation in the virus-driven induction of 
HERV-W elements cannot be ruled out though this does not occur at the ERVWE1 
locus. Sequence differences in the U3 regions of individual HERV-W elements 
determine a series of transcription factor binding motif, still unidentified transcription 
factors, thus, might play an important role in the transactivation of HERV-W following 
virus infection.  
      
Our observations based on the in vitro study are of potential relevance for 
understanding of conditions associated with aberrant transcription of HERV-W loci 
such as the psychiatric disorders; schizophrenia and bipolar disorder. The ChIP assays 
in this thesis reveal that chromatin changes potentially mediate the effects of 
environmental exposures (i.e. influenza A virus infection) on HERV-W. HERV-W 
expression may be a marker of chromatin changes, but also potentially directly 
involved in etiology or pathogenesis of human disorders. In addition to the indication of 
abnormal expression of HERV-W in patients, examining the differences of histone 
modifications between healthy and diseased individuals can help clinical researchers to 
address issues that are central for the development of better strategies for the prevention 
and treatment of these disorders.  
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